Serial [18F]-FDHT PET to Predict Bicalutamide Efficacy in Androgen Receptor–Positive Metastatic Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
European Journal of Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Serial [18F]-FDHT-PET to Predict Bicalutamide Efficacy in Patients With Androgen Receptor Positive Metastatic Breast Cancer
Eur. J. Cancer 2021 Feb 01;144(xx)151-161, J Boers, CM Venema, EFJ de Vries, GAP Hospers, HH Boersma, B Rikhof, C Dorbritz, AWJM Glaudemans, CP SchröderFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.